D46 | Ä¡·á°ü·Ã °ñ¼öÇü¼ºÀÌ»óÁõÈıº, »ó¼¼ºÒ¸í | Therapy related mtelodysplastic syndrome NOS |
 |
D460 | °í¸®Ã¶Àû¸ð±¸°¡ ¾ø´Â ºÒÀÀ¼º ºóÇ÷ | Refractory anemia without sideroblasts, so stated |
 |
D461 | °í¸®Ã¶Àû¸ð±¸°¡ ÀÖ´Â ºÒÀÀ¼º ºóÇ÷ | Refractory anemia with ring sideroblasts |
 |
D462 | ¸ð¼¼Æ÷°úÀ×ÀÇ ºÒÀÀ¼º ºóÇ÷ | Refractory anemia with excess of blasts |
 |
D462 | ¸ð¼¼Æ÷°úÀ×ÀÇ ºÒÀÀ¼º ºóÇ÷ ¥° | RAEB ¥° |
 |
D462 | ¸ð¼¼Æ÷¿ÍÀ×ÀÇ ºÒÀÀ¼º ºóÇ÷ ¥± | RAEB ¥± |
 |
D464 | »ó¼¼ºÒ¸íÀÇ ºÒÀÀ¼º ºóÇ÷ | Refractory anemia, unspecified |
 |
D465 | ´Ù¼¼Æ÷°è Çü¼ºÀÌ»óÀ» µ¿¹ÝÇÑ ºÒÀÀ¼º ºóÇ÷ | Refractory anemia with multi-lineage dysplasia |
 |
D466 | °í¸³¼º 5q °á½Ç ¿°»öüÀÌ»óÀ» µ¿¹ÝÇÑ °ñ¼öÇü¼ºÀÌ»óÁõÈıº | Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality |
 |
D466 | 5q-°á¼Õ ÁõÈıº | 5 q-minus syndrome |
 |
D467 | ±âŸ °ñ¼öÇü¼ºÀÌ»óÁõÈıº | Other myelodysplastic syndromes |
 |
D469 | »ó¼¼ºÒ¸íÀÇ °ñ¼öÇü¼ºÀÌ»óÁõÈıº | Myelodysplastic syndrome, unspecified |
 |
D469 | °ñ¼öÇü¼ºÀÌ»ó NOS | Myelodysplasia NOS |
 |
D469 | Àü¹éÇ÷º´(ÁõÈıº) NOS | Preleukaemia(syndrome) NOS |
 |
D47 | ¸²ÇÁ, Á¶Ç÷ ¹× °ü·ÃÁ¶Á÷ÀÇ Çൿ¾ç½Ä ºÒ¸í ¹× ¹Ì»óÀÇ ±âŸ ½Å»ý¹° | Other neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic and related tissue |
 |
D470 | Çൿ¾ç½Ä ºÒ¸í ¹× ¹Ì»óÀÇ Á¶Á÷±¸ ¹× ºñ¸¸¼¼Æ÷ Á¾¾ç | Histiocytic and mast cell tumours of uncertain and unknown behaviour |
 |
D470 | ÁøÇàÀÌ ´õµò ºñ¸¸¼¼Æ÷Áõ | Indolent systemic mastocytosis |
 |
D470 | ºñ¸¸¼¼Æ÷ Á¾¾ç NOS | Mast cell tumour NOS |
 |
D470 | ºñ¸¸¼¼Æ÷Á¾ NOS | Mastocytoma NOS |
 |
D470 | Ŭ·Ð Á¶Ç÷¼º ºñºñ¸¸¼¼Æ÷Áúȯ°ú °ü·ÃµÈ Àü½Å¼º ºñ¸¸¼¼Æ÷Áõ(SM-AHNMD) | Systemic mastocytosis, associated with clonal haematopoietic non-mast-cell disease |
 |